N1-Methyl-2'-O- (2-methoxyethyl) adenosine

N1-Methyl-2’-O- (2-methoxyethyl) adenosine is a synthetic purine nucleoside analog with broad-spectrum antitumor activity, notably effective against indolent lymphoid cancers. Its primary mechanisms involve inhibiting DNA synthesis and inducing apoptosis, as demonstrated in various in vitro and in vivo cancer research models.